| 373 |
Glibenclamide
|
|
None
|
| 506 |
glucocorticoids
|
|
309: Luteinizing hormone receptor antagonism leading to reproductive dysfunction
|
| 837 |
Gluten
|
|
524: Gluten-driven immune activation leading to celiac disease in genetically predisposed individuals
|
| 578 |
Glycyrrhizin
|
-
Glycyrrhizin, CAS-RN: 1405-86-3, DTXSID8047006
|
348: Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory
|
| 724 |
Gold
|
-
Gold, CAS-RN: 7440-57-5, DTXSID3064697
|
None
|
| 712 |
Gold nanoparticles
|
|
None
|
| 482 |
GOLPH3
|
|
None
|
| 530 |
Gossypol
|
-
Gossypol, CAS-RN: 303-45-7, DTXSID5023110
|
154: Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response
|
| 255 |
Graphene oxide nanoparticles
|
|
2 AOPs
|
| 151 |
GW6471
|
|
6: Antagonist binding to PPARα leading to body-weight loss
|
| 239 |
Halofenozide
|
-
Halofenozide, CAS-RN: 112226-61-6, DTXSID4032619
|
2 AOPs
|
| 788 |
Halogenated Hydrocarbons
|
|
519: Cardiac ion channels blockade leading to increased incidence of cardiovascular morbidity and mortality
|
| 160 |
Halogenated phenols
|
|
152: Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity
|
| 178 |
Haloperidol
|
-
Haloperidol, CAS-RN: 52-86-8, DTXSID4034150
|
2 AOPs
|
| 351 |
Halothane
|
-
Halothane, CAS-RN: 151-67-7, DTXSID4025371
|
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
|
| 620 |
HCoV-NL63
|
|
2 AOPs
|
| 675 |
Heavy metals (cadmium, lead, copper, iron, nickel)
|
|
7 AOPs
|
| 276 |
Helicobacter pylori
|
|
217: Gastric ulcer formation
|
| 299 |
Helicobacter pylori infection
|
|
229: Helicobacter pylori to gastric ulcer
|
| 344 |
Heptachlor
|
-
Heptachlor, CAS-RN: 76-44-8, DTXSID3020679
|
10: Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain
|
| 150 |
Hexachlorobenzene
|
-
Hexachlorobenzene, CAS-RN: 118-74-1, DTXSID2020682
|
131: Aryl hydrocarbon receptor activation leading to uroporphyria
|
| 500 |
High aspect ratio material
|
|
2 AOPs
|
| 646 |
high fat diet
|
|
403: combined unhealthy lifestyle factors leading to metabolic syndrome
|
| 503 |
High LET Ra
|
|
None
|
| 504 |
High LET Radiation
|
|
None
|